In line with these findings, mouse studies using either CD40L knockout mice or αCD40L blocking antibodies showed attenuated development of diet-induced obesity, hepatic steatosis and increased insulin sensitivity [41]. This evidence concerns the gene CD40LG and fatty liver disease.